A cancer patient gets a new lease on life

A cancer patient gets a new lease on life
tavasat1

/by

Empowering the next generation of healthcare leaders

Empowering the next generation of healthcare leaders
attila_novartis

/by

Empowering the next generation of healthcare leaders

Empowering the next generation of healthcare leaders
attila_novartis

/by

Giving voice to people with a misunderstood disease

Giving voice to people with a misunderstood disease
mihai_novartis

/by

Giving voice to people with a misunderstood disease

Giving voice to people with a misunderstood disease
mihai_novartis

/by

Water project revives rural community in India

Water project revives rural community in India
mihai_novartis

/by

Water project revives rural community in India

Water project revives rural community in India
mihai_novartis

/by

Novartis Lutathera® significantly reduced risk of disease progression or death by 72% as first-line treatment for patients with advanced gastroenteropancreatic neuroendocrine tumors

Novartis Lutathera® significantly reduced risk of disease progression or death by 72% as first-line treatment for patients with advanced gastroenteropancreatic neuroendocrine tumors
arcticnovartis

  • In the Phase III NETTER-2 trial, Lutathera plus octreotide LAR significantly extended median PFS to 22.8 months vs.
/by